Financial Performance - The Group's revenue for the six months ended September 30, 2021, was approximately HK$199.7 million, an increase of approximately HK$145.2 million or 266.4% compared to HK$54.5 million for the same period in 2020[9]. - Profit attributable to the owners of the Company was approximately HK$53.9 million for the six months ended September 30, 2021, compared to a loss of approximately HK$6.2 million for the same period in 2020[9]. - The profit before tax for the six months ended September 30, 2021, was HK$60.6 million, compared to a loss of HK$7.6 million for the same period in 2020[11]. - The total comprehensive income attributable to owners of the Company for the period was HK$126,000, compared to HK$30,000 in the same period of 2020[11]. - Earnings per share attributable to ordinary equity holders of the Company was HK$13.48 cents for the six months ended September 30, 2021, compared to a loss of HK$1.55 cents for the same period in 2020[11]. - The company reported a total comprehensive loss of HK$6,189,000 for the period[21]. - The Group reported record-high revenue of HK$199.7 million for the six months ended 30 September 2021, an increase of HK$145.2 million or 266.4% compared to the previous period[182]. - The Group achieved a profit of approximately HK$53.9 million for the period under review, reversing a net loss of approximately HK$6.2 million in the previous period[182]. Revenue Breakdown - Revenue from treatment services increased significantly to HK$176,594,000 for the six months ended September 30, 2021, compared to HK$50,566,000 in the same period of 2020, representing a growth of 248%[66]. - Revenue from skin care products rose to HK$22,775,000, up from HK$3,657,000, marking an increase of 523% year-over-year[66]. - Total revenue from contracts with customers reached HK$199,730,000, a substantial increase from HK$54,500,000, reflecting a growth of 267%[66]. - The Group recognized revenue of HK$112,550,000 from treatment services that was included in contract liabilities at the beginning of the reporting period, compared to HK$27,821,000 in the previous year, indicating a growth of 304%[72]. - The Group's revenue from Hong Kong was HK$195,358,000, while revenue from the PRC was HK$4,372,000, indicating a strong performance in the Hong Kong market[71]. Cost and Expenses - Staff costs increased to HK$56.4 million for the six months ended September 30, 2021, from HK$32.7 million in the same period of 2020[11]. - The cost of inventories and consumables was HK$13.3 million for the six months ended September 30, 2021, compared to HK$5.6 million in the same period of 2020[11]. - Property rentals and related expenses rose by approximately HK$7.1 million or 68.3%, from approximately HK$10.4 million in the previous period to approximately HK$17.5 million in the review period[198]. - Other expenses increased by approximately HK$30.5 million or 227.6%, from approximately HK$13.4 million in the previous period to approximately HK$43.9 million in the review period[200]. Assets and Liabilities - Total non-current assets increased to HK$195,567,000 as of September 30, 2021, up from HK$94,157,000 as of March 31, 2021, representing a growth of 107%[14]. - Current assets totaled HK$286,852,000, an increase from HK$277,978,000, reflecting a growth of 3.14%[14]. - Net current assets rose to HK$95,428,000, compared to HK$83,673,000, indicating an increase of 14.5%[17]. - Total liabilities decreased slightly to HK$282,800,000 from HK$286,561,000, a reduction of 1%[17]. - Total equity increased to HK$199,619,000, up from HK$145,574,000, marking a growth of 37%[17]. - Inventories surged to HK$33,142,000, compared to HK$14,154,000, representing an increase of 134%[14]. - Trade receivables increased significantly to HK$37,810,000 from HK$16,263,000, a growth of 132%[14]. - Credit card receivables increased to HK$37,748,000 from HK$16,344,000, indicating a growth of 130.5%[120]. Cash Flow - Cash generated from operations was a net outflow of HK$25,597,000, compared to a positive cash flow of HK$17,489,000 in the prior year[40]. - Net cash flows used in investing activities amounted to HK$4,087,000, a decrease from cash inflow of HK$14,656,000 in the previous period[45]. - Total cash and cash equivalents at the end of the period were HK$102,338,000, down from HK$109,453,000 at the end of the previous period[45]. - Cash and cash equivalents decreased to HK$112,338,000 from HK$161,773,000, a decline of 30.5%[14]. Strategic Developments - The Group operates three "CosMax" brand medical aesthetic centres located in Causeway Bay, Central District, and Tsim Sha Tsui, with a total of 30 treatment rooms in the Causeway Bay centre alone[183]. - The Group launched a new beauty brand "VITAE" with a focus on "Healthy Beauty," emphasizing the balance between beauty and health[184]. - The Group signed two new lease agreements for new centres in prime locations, including New World Tower II and Peninsula Office Tower, to expand its business[184]. - The Group plans to open new medical aesthetic service centers and skincare product retail stores in Hong Kong in FY2022 to deepen market penetration[192]. Accounting and Compliance - The company adopted revised accounting standards, including amendments related to interest rate benchmark reform and Covid-19-related rent concessions[56]. - The Group early adopted amendments to HKFRS 16, allowing for rent concessions due to the COVID-19 pandemic, which will apply to concessions affecting payments due on or before June 30, 2022[61]. - The amendments related to interest rate benchmark reform did not impact the Group's financial position or performance[59]. - The Group's financial reporting includes additional disclosures to help users understand the effects of interest rate benchmark reform on financial instruments and risk management strategies[59].
卓珈控股(01827) - 2022 - 中期财报